Goldman Sachs’s CEL-SCI Corp CVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-395
Closed -$27.8K 5964
2022
Q4
$27.8K Sell
395
-176
-31% -$15.5K ﹤0.01% 5668
2022
Q3
$53K Sell
571
-476
-45% -$57.4K ﹤0.01% 5795
2022
Q2
$141K Sell
1,047
-10,402
-91% -$1.08M ﹤0.01% 5753
2022
Q1
$1.35M Buy
11,449
+9,162
+401% +$1.49M ﹤0.01% 4580
2021
Q4
$487K Buy
2,287
+507
+28% +$155K ﹤0.01% 5410
2021
Q3
$587K Buy
1,780
+838
+89% +$244K ﹤0.01% 5102
2021
Q2
$245K Sell
942
-1,209
-56% -$748K ﹤0.01% 5636
2021
Q1
$981K Sell
2,151
-926
-30% -$506K ﹤0.01% 4631
2020
Q4
$1.08M Sell
3,077
-1,332
-30% -$525K ﹤0.01% 4153
2020
Q3
$1.69M Sell
4,409
-13,266
-75% -$5.23M ﹤0.01% 3693
2020
Q2
$7.91M Buy
17,675
+16,493
+1,395% +$6.77M ﹤0.01% 2442
2020
Q1
$409K Buy
1,182
+604
+104% +$221K ﹤0.01% 4323
2019
Q4
$159K Buy
578
+139
+32% +$32.8K ﹤0.01% 4951
2019
Q3
$118K Buy
+439
New +$103K ﹤0.01% 4936

Other funds holding CVM

Goldman Sachs's CVM Position: Q1 2023 in Review

Goldman Sachs sold out of CEL-SCI Corp (CVM) in Q1 2023, closing a stake of 395 shares — an estimated $27.8K sold.

Goldman Sachs first reported a position in CVM in Q3 2019 and held it in 14 quarters. The position peaked at $7.91M in Q2 2020. 62 funds tracked by Wall St. Rank hold CVM as of Q1 2023.

  • Goldman Sachs reported no remaining CEL-SCI Corp position as of Q1 2023 after selling out during the quarter.
  • Goldman Sachs sold 395 CEL-SCI Corp shares in Q1 2023, an estimated $27.8K.
  • Goldman Sachs first reported a position in CEL-SCI Corp in Q3 2019 and held it in 14 quarters.
  • Goldman Sachs's CEL-SCI Corp position peaked at $7.91M in Q2 2020.
  • 62 funds tracked by Wall St. Rank held CEL-SCI Corp as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.